I think there&#x27;s some middle ground that could be found here. For arguments sake, how about:<p>1. A drug company can charge whatever it wants for a drug until some predefined multiple of the cost of developing the drug is recovered.<p>2. After that point, the patent expires and its up to the free market to determine prices.<p>Set the multiple of R&amp;D costs high enough that it allows for the low success rate of drug research, and you have a model that still encourages risk taking whilst preventing profiteering.